MET inhibitor enhances efficacies of gemcitabine and olaparib in pancreatic cancer cells.

被引：0
|
作者：
Chen, Meikuang [1 ]
Gao, Yuan [2 ]
Yu, Dihua [1 ]
Hung, Mien-Chie [3 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Biliary Pancreat Surg, Shanghai, Peoples R China
[3] China Med Univ, Taichung, Taiwan
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB097
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Nuclear translocation of the receptor tyrosine kinase c-MET reduces the treatment efficacies of olaparib and gemcitabine in pancreatic ductal adenocarcinoma cells
    Gao, Yuan
    Chen, Mei-Kuang
    Chu, Yu-Yi
    Yang, Liuqing
    Yu, Dihua
    Liu, Yingbin
    Hung, Mien-Chie
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (01): : 236 - 250
  • [2] Triciribine Phosphate Monohydrate, an AKT Inhibitor, Enhances Gemcitabine Activity in Pancreatic Cancer Cells
    Kim, Richard
    Yamauchi, Teruo
    Husain, Kazim
    Sebti, Said
    Malafa, Mokenge
    ANTICANCER RESEARCH, 2015, 35 (09) : 4599 - 4604
  • [3] The PARP inhibitor olaparib enhances the cytotoxicity of combined gemcitabine, busulfan and melphalan in lymphoma cells
    Valdez, Benigno C.
    Li, Yang
    Murray, David
    Liu, Yan
    Nieto, Yago
    Champlin, Richard E.
    Andersson, Borje S.
    LEUKEMIA & LYMPHOMA, 2017, 58 (11) : 2705 - 2716
  • [4] Chidamide, a novel histone deacetylase inhibitor, synergistically enhances gemcitabine cytotoxicity in pancreatic cancer cells
    Qiao, Zhixin
    Ren, Suping
    Li, Weijing
    Wang, Xuanlin
    He, Min
    Guo, Yingjie
    Sun, Liwei
    He, Yuezhong
    Ge, Yubin
    Yu, Qun
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 434 (01) : 95 - 101
  • [5] Frondoside A Enhances the Antiproliferative Effects of Gemcitabine in Pancreatic Cancer Cells
    Al Shemaili, J.
    Parekh, K.
    Thomas, S. A.
    Halas, S. S.
    Al Sultan, M.
    Collin, P.
    Adrian, T. E.
    PANCREAS, 2011, 40 (08) : 1354 - 1354
  • [6] 4-methylumbelliferone, a hyaluronan synthase suppressor, enhances the anticancer activity of gemcitabine in human pancreatic cancer cells.
    Nakazawa H.
    Yoshihara S.
    Kudo D.
    Morohashi H.
    Kakizaki I.
    Kon A.
    Takagaki K.
    Sasaki M.
    Cancer Chemotherapy and Pharmacology, 2006, 57 (2) : 165 - 170
  • [7] Correlation of rnucin production with sensitivity to bortezomib and gemcitabine in pancreatic cancer cells.
    Wissniowski, T. T.
    Ocker, M.
    Hahn, E. G.
    Voll, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] Gemcitabine impacts expression of antigen presentation proteins by pancreatic cancer cells.
    Larson, Alaina C.
    Knoche, Shelby M.
    Solheim, Joyce C.
    CANCER RESEARCH, 2021, 81 (13)
  • [9] Piperlongumine enhances the efficacy of gemcitabine in pancreatic cancer cells in vitro and in vivo
    Mohammad, Jiyan
    Dhillon, Harsharan
    Reindl, Katie
    CANCER RESEARCH, 2016, 76
  • [10] A novel DDR1 inhibitor enhances the anticancer activity of gemcitabine in pancreatic cancer
    Ko, Soyeon
    Jung, Kyung Hee
    Yoon, Young -Chan
    Han, Beom Seok
    Park, Min Seok
    Lee, Yun Ji
    Kim, Sang Eun
    Cho, Ye Jin
    Lee, Pureunchowon
    Lim, Joo Han
    Ryu, Ji-Kan
    Kim, Kewon
    Kim, Tae Young
    Hong, Sungwoo
    Lee, So Ha
    Hong, Soon-Sun
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (09): : 4326 - 4342
12345